ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 53 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,666 | -31.5% | 23,000 | 0.0% | 0.00% | – |
Q4 2022 | $3,894 | -22.1% | 23,000 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | -58.3% | 23,000 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $12,000 | -7.7% | 23,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $13,000 | -7.1% | 23,000 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $14,000 | -36.4% | 23,000 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $22,000 | -12.0% | 23,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $25,000 | +13.6% | 23,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $22,000 | +100.0% | 23,000 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $11,000 | -38.9% | 23,000 | 0.0% | 0.00% | -60.0% |
Q3 2020 | $18,000 | +50.0% | 23,000 | 0.0% | 0.01% | +66.7% |
Q2 2020 | $12,000 | +50.0% | 23,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $8,000 | -50.0% | 23,000 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $16,000 | 0.0% | 23,000 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $16,000 | -46.7% | 23,000 | 0.0% | 0.01% | -60.0% |
Q2 2019 | $30,000 | -38.8% | 23,000 | 0.0% | 0.02% | -44.4% |
Q1 2019 | $49,000 | – | 23,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenlight Capital | 1,000,000 | $1,100,000 | 0.07% |
Hayden Royal, LLC | 40,015 | $44,000 | 0.02% |
Verdence Capital Advisors LLC | 143,382 | $158,000 | 0.02% |
Founders Capital Management | 18,000 | $20,000 | 0.01% |
WOLFF WIESE MAGANA LLC | 10,740 | $12,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 1,622,510 | $1,785,000 | 0.01% |
Global Strategic Investment Solutions, LLC | 23,000 | $25,000 | 0.00% |
Stonebridge Capital Advisors LLC | 44,000 | $45,000 | 0.00% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $110,000 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 97,590 | $107,000 | 0.00% |